Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Clinical trial NCT04046445 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04046445
Sponsor: Amal Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer MSS Stage IV Colon Cancer Stage IV Rectal Cancer Metastatic Colorectal Cancer Liver Metastasis Colon Cancer

Start date: 2019-07-22
Primary completion: 2025-05-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.